Ibuprofen 400MG/600MG/800MG Tablets

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-24-D-0003

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents3
This procurement notice pertains to the ongoing contract for the supply of Ibuprofen tablets in 400MG, 600MG, and 800MG dosages, managed by DLA Troop Support, a federal office responsible for providing logistical support to the Department of Defense and other federal agencies. The contract, identified by SPE2D2-24-D-0003, falls under the North American Industry Classification System (NAICS) code 325412, which covers Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating drugs and biologicals. The current notice is an award modification, specifically Modification P00002, which exercises Option Year 1 of the contract. This extension is effective from February 12, 2025, through February 11, 2026, ensuring the continued supply of Ibuprofen tablets during this period. Additionally, a previous modification (P00001) incorporated language from FAR 52.204-30, addressing Federal Acquisition Supply Chain Security Act Orders, into the solicitation. This inclusion underscores the contract’s compliance with federal supply chain security requirements, which is a critical consideration for pharmaceutical suppliers. The scope of this procurement centers on the reliable manufacturing and delivery of Ibuprofen tablets in specified strengths, supporting the medical and operational needs of federal entities. Contractors are expected to adhere to stringent quality standards and regulatory requirements associated with pharmaceutical manufacturing and federal supply chain security. The intended outcome is to maintain an uninterrupted supply of these essential medications, contributing to the health and readiness of personnel served by DLA Troop Support. Key requirements for this contract include the ability to produce and deliver Ibuprofen tablets in the specified dosages, compliance with all applicable federal regulations, and adherence to the terms outlined in the contract modifications. The incorporation of FAR 52.204-30 language highlights the importance of secure and compliant supply chain practices throughout the contract lifecycle. The contracting entity, DLA Troop Support, is based in the United States and can be contacted for further information through the primary contact, Kyle Lewicki ([email protected], 215-737-3696), or the secondary contact, Jason Wray ([email protected], 215-737-0614). The notice remains active as of the posting date, May 2, 2025, and additional details, including attachments, can be accessed via the official SAM.gov opportunity page. This opportunity is best suited for contractors with established capabilities in pharmaceutical manufacturing, robust supply chain security measures, and experience in federal contracting. The contract’s requirements and objectives are expected to remain consistent throughout its lifecycle, focusing on the secure, compliant, and timely provision of Ibuprofen tablets to meet federal needs.